Are trans-complementation systems suitable for hepatitis C virus life cycle studies? - Wikidata - awgldk - TriplyDB

Are trans-complementation systems suitable for hepatitis C virus life cycle studies?

Are trans-complementation systems suitable for hepatitis C virus life cycle studies?

http://www.wikidata.org/entity/Q38089384

about

Identification of novel RNA secondary structures within the hepatitis C virus genome reveals a cooperative involvement in genome packaging Genetic Analysis of Serum-derived HCV Defective Genomes Revealed Novel Viral Cis-Elements for Virus Replication and Assembly.

P2860

Q38293248-8BAAF6BF-8F95-4731-B464-162E48FC80EA Q47549190-215E4D89-AC85-422D-BA79-E0C04C0B0F9C

P2860

Are trans-complementation systems suitable for hepatitis C virus life cycle studies?

http://www.wikidata.org/entity/Q38089384

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Are trans-complementation systems suitable for hepatitis C virus life cycle studies?

@en

type

label

Are trans-complementation systems suitable for hepatitis C virus life cycle studies?

@en

prefLabel

Are trans-complementation systems suitable for hepatitis C virus life cycle studies?

@en

P1433

Q38089384-607C4F4D-6377-43EE-8BC0-625173C20992

P1476

Q38089384-FBD96603-E93A-4077-9E65-5DF911F6A8F4

P2093

Q38089384-590538F3-DF3B-4232-94F8-B06F479CD45A

Q38089384-F6201E8B-8FB9-42BA-9012-374E4E654225

P2860

Q38089384-10DD6B4E-AB39-47AB-AD43-06415BFB0F18

Q38089384-1C47F725-DEC1-44BE-9494-77264A34A12D

Q38089384-20A21676-76D6-406A-B77E-6D9E66A6BADC

Q38089384-22254FFE-9024-427F-AF1A-81FC7F2DF91C

Q38089384-258CA403-6790-48AD-B27C-7C00C64416FB

Q38089384-291C1EA4-7FE3-419C-BF6F-7FFEF338AA05

Q38089384-30156D58-EFF0-4ABB-8918-7BDCFF0B1D64

Q38089384-31795A8B-E031-40A7-A537-4CC4AB47BE90

Q38089384-329BE716-2134-4AA6-83F7-46C1CC868AB7

Q38089384-329DCB6E-D4B9-4BDE-B827-F12B07D11D0A

P304

Q38089384-6CB8B1A5-3F07-452F-840A-C2BE7BB1DD9D

P31

Q38089384-418F817E-8C86-465E-A905-B3E321DA1678

P356

Q38089384-456C45C7-FCC2-43AB-AE23-50BADDC2BE47

P433

Q38089384-08F7DAD7-AEC2-4906-BDB2-C5FD4B0D1E30

P478

Q38089384-241D180C-6EAC-4365-906B-E3BD7A46BDEF

P50

Q38089384-E05162D6-1596-4A81-B0A0-A8A5DF82E10C

P577

Q38089384-B9442DAB-5A51-4768-AF8C-38BAF56886C6

P5875

Q38089384-4A416546-11ED-49DC-807F-261D06C29AD9

P698

Q38089384-09396BCD-6B18-42B4-9040-F33F6FB03FFF

P356

P1433

Journal of Viral Hepatitis

P1476

Are trans-complementation systems suitable for hepatitis C virus life cycle studies?

@en

P2093

C Fournier

http://www.w3.org/2001/XMLSchema#string

G Duverlie

http://www.w3.org/2001/XMLSchema#string

P2860

Classical swine fever virus E(rns) deletion mutants: trans-complementation and potential use as nontransmissible, modified, live-attenuated marker vaccines.

N-Linked Glycosylation of West Nile Virus Envelope Proteins Influences Particle Assembly and Infectivity

High-throughput assays using a luciferase-expressing replicon, virus-like particles, and full-length virus for West Nile virus drug discovery.

Kunjin virus replicon vaccine vectors induce protective CD8+ T-cell immunity.

Kunjin Virus Replicon Vectors for Human Immunodeficiency Virus Vaccine Development

Incorporation of Tick-Borne Encephalitis Virus Replicons into Virus-Like Particles by a Packaging Cell Line

High levels of subgenomic HCV plasma RNA in immunosilent infections

Characterization of Hepatitis C Virus Deletion Mutants Circulating in Chronically Infected Patients

Cell Culture Adaptation of Hepatitis C Virus and In Vivo Viability of an Adapted Variant

Essential Role of Domain III of Nonstructural Protein 5A for Hepatitis C Virus Infectious Particle Assembly

P304

225-233

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/JVH.12069

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

20

http://www.w3.org/2001/XMLSchema#string

P50

P577

2013-02-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

236046382

http://www.w3.org/2001/XMLSchema#string

P698

23490366

http://www.w3.org/2001/XMLSchema#string